Results 261 to 270 of about 90,671 (304)

Coronary Embolization of Valsalva Thrombus Following Transcatheter Aortic Valve Implantation. [PDF]

JACC Case Rep
Tsuru Y, Ishizu K, Hayashi M, Shirai S, Ando K.   +4 more
europepmc   +1 more source

Transcatheter Aortic Valve Implantation for Severe Bicuspid Aortic Stenosis With Concomitant Giant Cell Arteritis Aortitis. [PDF]

JACC Case Rep
Altnji I, Curtain JP, O'Connor S.
europepmc   +1 more source

Natural History of Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation. [PDF]

J Am Heart Assoc
Brown JA, Donohue J, Yousef S, Iyanna N, Ahmad D, Kliner D, Toma C, Serna-Gallegos D, Makani A, West D, Hasan I, Ogami T, Sultan I.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization

Nature Reviews Cardiology, 2022
Tian-Yuan Xiong, Kentaro Hayashida,, Fesc, Azeem Latib   +2 more
exaly   +2 more sources

Transcatheter Aortic Valve Implantation

Cardiology Clinics, 2010
In the 7 years since the first implant, more than 7000 transcatheter aortic valve implantations (TAVI) have been performed worldwide. This article describes the latest available information on this field and the upcoming technological expectations.
Raquel, Del Valle-Fernández, Claudia A, Martinez, Carlos E, Ruiz   +2 more
  +6 more sources

Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine
BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart-failure admission among high-risk patients. However, most patients with valvular heart disease, including those undergoing transcatheter aortic-valve implantation (TAVI)
S. Raposeiras-Roubín, I. Amat-Santos, Xavier Rosselló, Rocío González Ferreiro, I. González Bermúdez, Diego López Otero, L. Nombela‐Franco, L. Gheorghe, J. L. Díez, Carlos Baladrón Zorita, J. Baz, A. J. Muñoz García, V. Vilalta, Soledad Ojeda-Pineda, J. M. de la Torre Hernandez, J. G. Córdoba Soriano, A. Regueiro, Pascual Bordes Siscar, J. Salgado Fernández, B. García Del Blanco, R. Martín-Reyes, Rafael Romaguera, Cesar Moris, S. García Blas, J. Franco-Peláez, I. Cruz-González, D. Arzamendi, N. Romero Rodríguez, F. Díez-del Hoyo, S. C. Camacho Freire, Francisco Bosa Ojeda, J. C. Astorga Burgo, Eduardo Molina Navarro, Juan Caballero Borrego, Valeriano Ruiz Quevedo, Á. Sánchez-Recalde, Vicente Peral Disdier, Eduardo Alegría-Barrero, J. Torres-Llergo, Gisela Feltes, J. F. Fernández Díaz, C. Cuellas, Gustavo Jiménez Brítez, J. Sánchez-Rubio Lezcano, C. Barreiro-Pardal, I. Núñez-Gil, E. Abu-Assi, A. Iñíguez-Romo, Valentín Fuster, Borja Ibáñez   +49 more
semanticscholar   +1 more source

Transcarotid transcatheter aortic valve implantation

Multimedia Manual of Cardio-Thoracic Surgery, 2016
Transcatheter aortic valve implantation is a well-recognized treatment option for high-risk patients with aortic stenosis. The femoral approach is possible in 80% of cases. Initially, only the transcarotid and subclavian approaches were performed as alternative routes. Both approaches have advantages and disadvantages.
Nicolas, Laurent, Pablo, Maureira, Maxime, Bertram, Mazen, Elfarra, Fabrice, Vanhuyse, Daniel, Grandmougin, Michael, Angioi, Thierry A, Folliguet   +7 more
openaire   +2 more sources

Balloon versus self‐expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta‐analysis of observational studies

Catheterization and cardiovascular interventions, 2021
There is a rising trend for transcatheter aortic valve implantation (TAVI) in bicuspid aortic stenosis patients. Data on the use of self‐expandable (SEV) vs. balloon‐expandable (BEV) valves in these patients are scarce.
M. Sá, M. Simonato, Jef Van den Eynde, L. R. P. Cavalcanti, A. Alsagheir, A. Tzani, L. N. Fovino, Polydoros N. Kampaktsis, M. Gallo, P. Laforgia, A. Ruhparwar, A. Weymann, S. Hirji, T. Kaneko, Gilbert H L Tang   +14 more
semanticscholar   +1 more source

PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine
BACKGROUND The benefit of percutaneous coronary intervention (PCI) in patients with stable coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic-valve implantation (TAVI) remains unclear. METHODS In an international
J. Lønborg, R. Jabbari, Muhammad Sabbah, K. Veien, M. Niemelä, Phillip Freeman, R. Linder, D. Ioanes, C. Terkelsen, Olli A Kajander, S. Koul, M. Savontaus, P. Karjalainen, A. Erglis, Mikko Minkkinen, Rikke Sørensen, H. Tilsted, L. Holmvang, Gintautas Bieliauskas, J. Ellert, J. Piuhola, A. Eftekhari, Oskar Angerås, A. Rück, E. H. Christiansen, T. Jørgensen, B. T. Özbek, C. Glinge, Lars Søndergaard, O. de Backer, Thomas Engstrøm   +30 more
semanticscholar   +1 more source